Pyzchiva is approved for treatment of adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and in certain pediatric plaque psoriasis patients.
Generic drug companies continue to face obstacles, but there is no substitute for the solutions they are implementing to meet the needs of customers and patients.